Goldman Sachs and 6 other SEBI-registered analysts issued 9 long term recommendations across 8 stocks for long-term portfolio allocation, with a bullish bias.
Goldman Sachs and 6 other SEBI-registered analysts issued 9 equity long term recommendations today, targeting multi-month to multi-year investment horizons. The batch carries a bullish bias — 9 buys against 0 sells — covering 8 stocks.
The 5 most-covered names of the session:
ANGELONE attracted 2 separate recommendations from 2 SEBI-registered analysts — Jefferies (SEBI Reg. INH000000701) issued a buy at ₹305, targeting ₹2,480; Nomura (SEBI Reg. INH000001014) issued a buy at ₹305, targeting ₹2,450.
GODREJCP was flagged for a buy by Goldman Sachs (SEBI Reg. INH000001493) at ₹867, targeting ₹3,870 — a potential upside of +346.4%.
HINDUNILVR was flagged for a buy by HSBC (SEBI Reg. INH000001287) at ₹1,973, targeting ₹2,440 — a potential upside of +23.7%.
INDUSTOWER was flagged for a buy by Goldman Sachs (SEBI Reg. INH000001493) at ₹381, targeting ₹3,870 — a potential upside of +915.7%.
MAXHEALTH was flagged for a buy by Goldman Sachs (SEBI Reg. INH000001493) at ₹990, targeting ₹3,870 — a potential upside of +290.9%.
The remaining 3 stocks covered by SEBI-registered analysts, with the price at which each call was issued:
Buy calls — MOREPENLAB (₹117.9 → ₹128.1) via Motilaloswalofficial; PNB (₹116) via Somil Mehta; WAKEFIT (₹156 → ₹190) via IIFLCapitalA.
This roundup reproduces calls from 7 SEBI-registered Research Analysts: Goldman Sachs (SEBI Reg. INH000001493); HSBC (SEBI Reg. INH000001287); IIFLCapitalA (SEBI Reg. INH000000248); Jefferies (SEBI Reg. INH000000701); Motilaloswalofficial (SEBI Reg. INH000000412); Nomura (SEBI Reg. INH000001014); Somil Mehta (SEBI Reg. INH000006183).
Long-term picks are best accumulated on dips. Investors should review fundamentals periodically and maintain position sizing discipline.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.